Inside informationEnglish
bioMérieux receives U.S. FDA clearance for the new version of its molecular test targeting causes of gastroenteritis, BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Biomerieux
- Filed
- 11/02/2025, 14:53
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 077451_20250211